Stryker Corp
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Trauma and Extremities by Quarter
Trauma and Extremities (Core Trauma, Upper Extremities / Shoulder & Foot/Ankle) — Worldwide Net Sales ($M) ($M)
Stryker Trauma and Extremities: $1,010M in Q3 2026, up 5.2% from a year earlier.
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Supplemental Sales Schedules, Recast 8-K & Form 10-K/10-Q Note 15.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up trauma and Extremities
- Trauma and Extremities (Core Trauma, Upper Extremities / Shoulder & Foot/Ankle) — Worldwide Constant Currency Sales Growth YoY (%)5.5% · Q3 2026
- Trauma and Extremities (Core Trauma, Upper Extremities / Shoulder & Foot/Ankle) — Worldwide Reported Sales Growth YoY (%)5.3% · Q3 2026
- Trauma and Extremities (Core Trauma, Upper Extremities / Shoulder & Foot/Ankle) — U.S. Net Sales ($M)735 · Q3 2026
- Trauma and Extremities (Core Trauma, Upper Extremities / Shoulder & Foot/Ankle) — International Net Sales ($M)275 · Q3 2026
Cite this data
StockData. (2026). Stryker Trauma and Extremities ($M), quarterly Q4 2014–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-trauma-ww-rev
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.